Jackson Creek Investment Advisors LLC Takes Position in Astera Labs, Inc. (NASDAQ:ALAB)

Jackson Creek Investment Advisors LLC bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,558 shares of the company's stock, valued at approximately $604,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Hollencrest Capital Management acquired a new stake in Astera Labs in the 3rd quarter worth approximately $26,000. Steward Partners Investment Advisory LLC raised its position in shares of Astera Labs by 99.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company's stock valued at $26,000 after purchasing an additional 99 shares during the period. Kestra Investment Management LLC acquired a new stake in shares of Astera Labs in the fourth quarter worth $28,000. Geneos Wealth Management Inc. bought a new stake in shares of Astera Labs during the 4th quarter worth $36,000. Finally, Global Retirement Partners LLC grew its stake in Astera Labs by 3,155.6% in the 4th quarter. Global Retirement Partners LLC now owns 293 shares of the company's stock valued at $39,000 after buying an additional 284 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB traded down $4.41 on Monday, hitting $62.51. The stock had a trading volume of 1,579,002 shares, compared to its average volume of 3,781,694. The firm's 50 day moving average price is $104.47 and its 200-day moving average price is $87.77. Astera Labs, Inc. has a twelve month low of $36.22 and a twelve month high of $147.39. The company has a market capitalization of $10.14 billion and a price-to-earnings ratio of -36.13.

Remove Ads

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing analysts' consensus estimates of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. As a group, sell-side analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Stifel Nicolaus raised their price target on Astera Labs from $100.00 to $150.00 and gave the company a "buy" rating in a research report on Monday, January 6th. Craig Hallum lifted their price target on Astera Labs from $105.00 to $125.00 and gave the stock a "buy" rating in a research report on Tuesday, February 11th. Needham & Company LLC reiterated a "buy" rating and set a $140.00 price target on shares of Astera Labs in a report on Tuesday, February 11th. Barclays raised their price objective on shares of Astera Labs from $87.00 to $135.00 and gave the stock an "overweight" rating in a research note on Friday, January 17th. Finally, Northland Securities upgraded shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 target price for the company in a research note on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $115.33.

Insiders Place Their Bets

In other news, CFO Michael Truett Tate sold 125,800 shares of the business's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $82.53, for a total transaction of $10,382,274.00. Following the completion of the sale, the chief financial officer now owns 244,242 shares in the company, valued at $20,157,292.26. The trade was a 34.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jitendra Mohan sold 350,680 shares of the company's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $89.51, for a total value of $31,389,366.80. Following the transaction, the chief executive officer now directly owns 2,353,655 shares in the company, valued at $210,675,659.05. This trade represents a 12.97 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 570,990 shares of company stock valued at $50,242,702.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.